JNJ · News · 20261022N

Hong Kong Strategic Collaboration

JOHNSON & JOHNSON · 2026-10-22 · Importance 31 · Surprise 42

Johnson & Johnson was selected as a Strategic Enterprise by Hong Kong SAR’s Office for Attracting Strategic Enterprises on October 22, 2026. The collaboration is intended to strengthen clinical research, develop healthcare talent and support Hong Kong’s goal of becoming an international health and medical innovation hub. The announcement builds on more than five decades of J&J operations and collaboration in Hong Kong, but does not disclose a financial commitment or implementation timetable.

Key facts

• Johnson & Johnson was selected as a Strategic Enterprise by the Hong Kong SAR Government's Office for Attracting Strategic Enterprises (OASES). source
• Johnson & Johnson is building on more than five decades in Hong Kong as part of its commitment to advancing better health through science, innovation and collaboration for patients and communities in Hong Kong. source